Title |
Identifying high-risk medication: a systematic literature review
|
---|---|
Published in |
European Journal of Clinical Pharmacology, March 2014
|
DOI | 10.1007/s00228-014-1668-z |
Pubmed ID | |
Authors |
Eva A. Saedder, Birgitte Brock, Lars Peter Nielsen, Dorthe K. Bonnerup, Marianne Lisby |
Abstract |
A medication error (ME) is an error that causes damage or poses a threat of harm to a patient. Several studies have shown that only a minority of MEs actually causes harm, and this might explain why medication reviews at hospital admission reduce the number of MEs without showing an effect on length of hospital stay, readmissions, or death. The purpose of this study was to define drugs that actually cause serious MEs. We conducted a literature search of medication reviews and other preventive efforts. |
X Demographics
The data shown below were collected from the profiles of 372 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 152 | 41% |
Chile | 9 | 2% |
Venezuela, Bolivarian Republic of | 7 | 2% |
Argentina | 4 | 1% |
Colombia | 4 | 1% |
Mexico | 4 | 1% |
United Kingdom | 4 | 1% |
Ireland | 3 | <1% |
Canada | 3 | <1% |
Other | 11 | 3% |
Unknown | 171 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 305 | 82% |
Practitioners (doctors, other healthcare professionals) | 54 | 15% |
Scientists | 8 | 2% |
Unknown | 5 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 190 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 1% |
Spain | 2 | 1% |
Finland | 1 | <1% |
Belgium | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 183 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 31 | 16% |
Student > Ph. D. Student | 24 | 13% |
Researcher | 20 | 11% |
Student > Postgraduate | 14 | 7% |
Student > Bachelor | 12 | 6% |
Other | 37 | 19% |
Unknown | 52 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 55 | 29% |
Pharmacology, Toxicology and Pharmaceutical Science | 40 | 21% |
Nursing and Health Professions | 13 | 7% |
Social Sciences | 5 | 3% |
Agricultural and Biological Sciences | 5 | 3% |
Other | 13 | 7% |
Unknown | 59 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 276. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2023.
All research outputs
#131,909
of 25,732,188 outputs
Outputs from European Journal of Clinical Pharmacology
#3
of 2,775 outputs
Outputs of similar age
#1,039
of 238,814 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#1
of 22 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,775 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,814 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.